好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Creutzfeldt-Jakob Disease Masquerading as Autoimmune Encephalitis
Aging, Dementia, and Behavioral Neurology
P2 - Poster Session 2 (5:30 PM-6:30 PM)
9-033

Distinguishing between the causes of rapidly progressive dementia can be difficult, yet diagnostic clarity is important for treatment decisions and prognostication.

N/A

A 62-year-old woman from Minnesota presented with rapidly progressive gait instability. Two months prior to presentation, she had developed imbalance followed by lightheadedness, periodic tremulousness, nighttime headaches, and a marked decrease in energy and ability to walk. She was unable to continue her office job and stopped driving. Initial neuroimaging was unremarkable. During the next month, she developed binocular horizontal and vertical diplopia, somnolence, and worsening tremor and ataxia. Her husband noted memory decline and new violent jerking movements upon falling asleep. On exam, she had orthostatic hypotension, fine hand tremor bilaterally, square wave jerks, and an unsteady wide-based gait. Repeat MRI showed T2-hyperintensity in the right medial temporal lobe, right basal ganglia, and caudate. Cerebrospinal fluid (CSF) was non-inflammatory and infectious testing was negative. Autoimmune encephalitis panel in CSF and serum were unrevealing. Cancer screen with mammogram, colonoscopy and CT-PET scan was normal. Intravenous methylprednisolone was started for possible autoimmune limbic encephalitis, but she continued to worsen and was admitted to the general neurology service after a fall resulting in a wrist fracture. Repeat MRI showed cortical ribboning with T2-signal and diffusion imaging abnormalities in the caudate, thalamus, and hippocampus. CSF testing at the Prion Disease Laboratory revealed abnormally elevated RT-QuIC, total tau, and 14-3-3 protein highly suggestive of Creutzfeldt-Jakob Disease (CJD). Her husband disclosed that they occasionally hunt and eat wild game. She continued to rapidly decline and was transitioned to hospice care. 

N/A

We highlight a case of Creutzfeldt-Jakob Disease with mesial temporal T2-hyperintensity mimicking autoimmune encephalitis. Cerebrospinal fluid RT-QuIC is a useful highly specific confirmatory test for CJD.

Authors/Disclosures
Sushma Kola, MD
PRESENTER
Dr. Kola has nothing to disclose.
Eoin P. Flanagan, MBBCh, FAAN (Mayo Clinic) The institution of Dr. Flanagan has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche. Dr. Flanagan has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Pharmacy times. The institution of Dr. Flanagan has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for UCB. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Roche. The institution of Dr. Flanagan has received research support from UCB. The institution of Dr. Flanagan has received research support from Merck. The institution of Dr. Flanagan has received research support from Roche. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has received publishing royalties from a publication relating to health care. Dr. Flanagan has a non-compensated relationship as a Member of medical Advisory Board with The MOG Project that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Journal of The Neurologic Sciences that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial board member with Neuroimmunology Reports that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology, Neuroimmunology Neuroinflammation (N2) Journal that is relevant to AAN interests or activities. Dr. Flanagan has a non-compensated relationship as a Editorial Board Member with Neurology that is relevant to AAN interests or activities.
David T. Jones, MD (Mayo Clinic) Dr. Jones has stock in Cephlodyne Neurotechnologies, Inc.. Dr. Jones has received intellectual property interests from a discovery or technology relating to health care.